Publicacións (176) Publicacións de Rogelio Manuel Leira Muiño

2024

  1. Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review

    Frontiers in Neurology , Vol. 15

2023

  1. Association between periodontitis and peripheral markers of innate immunity activation and inflammation

    Journal of Periodontology, Vol. 94, Núm. 1, pp. 11-19

  2. Periodontal inflammation is associated with increased circulating levels of endothelial progenitor cells: a retrospective cohort study in a high vascular risk population

    Therapeutic Advances in Chronic Disease, Vol. 14

2022

  1. Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

    Neurologia, Vol. 37, Núm. 5, pp. 390-402

2021

  1. 1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress

    Revista de Neurologia

  2. Document of revision and updating of medication overuse headache (MOH)

    Neurologia, Vol. 36, Núm. 3, pp. 229-240

  3. Interictal amylin levels in chronic migraine patients: A case-control study

    Cephalalgia, Vol. 41, Núm. 5, pp. 604-612

  4. MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention

    Journal of Headache and Pain, Vol. 22, Núm. 1

  5. Mild systemic inflammation enhances response to OnabotulinumtoxinA in chronic migraineurs

    Scientific Reports, Vol. 11, Núm. 1

  6. The impact of a digital platform on migraine patient-centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish

    Headache, Vol. 61, Núm. 9, pp. 1403-1410

2020

  1. Author response: Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine

    Neurology

  2. Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine

    Neurologia, Vol. 35, Núm. 8, pp. 568-578

  3. Iron Deposits in Periaqueductal Gray Matter Are Associated with Poor Response to OnabotulinumtoxinA in Chronic Migraine

    Toxins, Vol. 12, Núm. 8

  4. Pentraxin 3 (PTX3): A molecular marker of endothelial dysfunction in chronic migraine

    Journal of Clinical Medicine, Vol. 9, Núm. 3

  5. Prolonged Migraine Stuttering Aura: Structural, Functional, and Video Neuroimaging Study of an Atypical Migraine Aura. A Case Report

    Headache, Vol. 60, Núm. 4, pp. 776-780

  6. Severe periodontitis is linked with increased peripheral levels of sTWEAK and PTX3 in chronic migraineurs

    Clinical Oral Investigations, Vol. 24, Núm. 2, pp. 597-606

2019

  1. Association between periodontitis and chronic migraine: a case–control study

    Odontology, Vol. 107, Núm. 1, pp. 90-95

  2. Cefalea en racimos y cefaleas secundarias

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 71, pp. 4163-4174

  3. Cluster headache and secondary headaches

    Medicine (Spain), Vol. 12, Núm. 71, pp. 4163-4174

  4. Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice

    Neurologia, Vol. 34, Núm. 6, pp. 408-417